On July 6, 2017, NCATS officially opened its Stem Cell Translation Laboratory (SCTL), which is supported through the NIH Common Fund. SCTL scientists are seeking proposals to collaborate on projects to bring pluripotent stem cell technology closer to clinical application, drug discovery and regenerative medicine. Learn more about stem cell research at NCATS.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- NCATS Chemical Genomics Center (NCGC)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Trans-NIH RNAi Facility (TNRF)
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- Stories & Publications
- NCATS E-Newsletter
- Past E-Newsletter Issues
- NCATS Stem Cell Translation Laboratory Grand Opening
NCATS Stem Cell Translation Laboratory Grand Opening
- Funding & Notices
-